Perrigo Company (PRGO) Stock Analysis & Winston Score

Perrigo is a company that makes store-brand, over-the-counter medicines and health products. Think of the generic pain relievers, allergy pills, cough syrups, and baby formula you see at Walmart, CVS, or Target with the store's own label — Perrigo likely made them. The company sells mostly to large retailers and drugstore chains, who then sell the products under their own brand names. Perrigo earns money by manufacturing these products at scale and selling them to retailers at a lower price than name-brand alternatives. It operates mainly in North America and Europe, with a market cap of about $1.4 billion, making it a mid-sized player in the generic consumer health space. Its competitive edge comes from long-standing retailer relationships and the complexity of getting FDA approval for generic products, which keeps some competitors out. However, the company carries significant debt and its low operating margin of roughly 6% leaves little room for error if sales slow or costs rise.